News

Innovation Norway grants NorDiag risk loan of NOK 4 million

Market Making Agreement

NorDiag Q2-2008: Prototype of new cancer test completed

Invitation to Q2 and first half year 2008 presentation

Børsmelding fra Novel Diagnostics vedrørende NorDiag

New share capital registered

Mandatory notification of trade

Disclosure of shareholding

Allotment of shares to primary insiders

NORDIAG ASA- Result public offering

Oslo Børs - NORD T - last day of listing today

NorDiag ASA grants license to Institute Pasteur de Lille, France

Subscription of NorDiag shares starts today

Approved Prospectus

Oslo Børs - NORD T - Listed tomorrow

First NorDiag contract in US

Option scheme for employees in NorDiag

Ex subscription rights today

Extraordinary General Meeting held in NorDiag

Pages